Off-Label Marketing On Shaky Ground
The U.S. Department of Justice's ("DOJ") prosecution of pharmaceutical and medical device companies for alleged off-label marketing and the Food and Drug Administration's ("FDA") recent attempt to provide parameters for such...To view the full article, register now.
Already a subscriber? Click here to view full article